Cytomegalovirus (CMV), Antibody |
|||
| GWB-3DA3A6 | GenWay Biotech | 1 mg | Ask for price |
Cytomegalovirus Antibody Laboratories manufactures the t cytomegalovirus cmv reagents distributed by Genprice. The T Cytomegalovirus Cmv reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact cytomegalovirus Antibody. Other T products are available in stock. Specificity: T Category: Cytomegalovirus Group: Cmv
Cytomegalovirus Antibody / CMV / PP65 |
||
| NSJ Bioreagents | 100 ug | 424.15 EUR |
|
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop Cytomegalovirus infections. In some patients with AIDS, the virus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of the disease. An indicator of active infection is needed to facilitate the diagnosis of cytomgalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus was detected in the leukocytes of both the peripheral blood and BALF during the early phase of the disease. |
||
Cytomegalovirus Antibody / CMV / PP65 |
||
| NSJ Bioreagents | 20 ug | 186.15 EUR |
|
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop Cytomegalovirus infections. In some patients with AIDS, the virus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of the disease. An indicator of active infection is needed to facilitate the diagnosis of cytomgalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus was detected in the leukocytes of both the peripheral blood and BALF during the early phase of the disease. |
||
Cytomegalovirus Antibody / CMV / PP65 |
||
| NSJ Bioreagents | 100 ug | 424.15 EUR |
|
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop Cytomegalovirus infections. In some patients with AIDS, the virus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of the disease. An indicator of active infection is needed to facilitate the diagnosis of cytomgalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus was detected in the leukocytes of both the peripheral blood and BALF during the early phase of the disease. |
||
Cytomegalovirus Antibody / CMV / PP65 |
||
| NSJ Bioreagents | 100 ug | 424.15 EUR |
|
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, cytomegalovirus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of cytomegalovirus disease. An indicator of active CMV infection is needed to facilitate the diagnosis of cytomegalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease. |
||
Cytomegalovirus Antibody / CMV / PP65 |
||
| NSJ Bioreagents | 20 ug | 186.15 EUR |
|
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, cytomegalovirus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of cytomegalovirus disease. An indicator of active CMV infection is needed to facilitate the diagnosis of cytomegalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease. |
||
Cytomegalovirus Antibody / CMV / PP65 |
||
| NSJ Bioreagents | 100 ug | 424.15 EUR |
|
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, cytomegalovirus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of cytomegalovirus disease. An indicator of active CMV infection is needed to facilitate the diagnosis of cytomegalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease. |
||
Cytomegalovirus (CMV) IgG |
||
| Demeditec Diagnostics | 96 | 98 EUR |
Cytomegalovirus (CMV) IgM ELISA Kit |
|||
| K4151-100 | Biovision | each | 646.8 EUR |
Cytomegalovirus gH (CMV gH) Antibody |
|||
| abx415688-01mg | Abbexa | 0.1 mg | 777.6 EUR |
Cytomegalovirus (CMV) gp B, Antibody |
|||
| GWB-B9CB2E | GenWay Biotech | 0.1 mg | Ask for price |
Cytomegalovirus gH (CMV gH) Antibody |
|||
| abx415688-200l | Abbexa | 200 µl | 650 EUR |
Mouse Cytomegalovirus (CMV) ELISA Kit |
|||
| SL0952Mo | Sunlong | - | Ask for price |
Chicken Cytomegalovirus (CMV)ELISA Kit |
|||
| SL0197Ch | Sunlong | - | Ask for price |
Cytomegalovirus Antibody / CMV / PP65 |
|||
| V2332-100UG | NSJ Bioreagents | 100 ug | 424.15 EUR |
|
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop Cytomegalovirus infections. In some patients with AIDS, the virus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of the disease. An indicator of active infection is needed to facilitate the diagnosis of cytomgalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus was detected in the leukocytes of both the peripheral blood and BALF during the early phase of the disease. |
|||
Cytomegalovirus Antibody / CMV / PP65 |
|||
| V2332-20UG | NSJ Bioreagents | 20 ug | 186.15 EUR |
|
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop Cytomegalovirus infections. In some patients with AIDS, the virus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of the disease. An indicator of active infection is needed to facilitate the diagnosis of cytomgalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus was detected in the leukocytes of both the peripheral blood and BALF during the early phase of the disease. |
|||
Cytomegalovirus Antibody / CMV / PP65 |
|||
| V2332SAF-100UG | NSJ Bioreagents | 100 ug | 424.15 EUR |
|
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop Cytomegalovirus infections. In some patients with AIDS, the virus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of the disease. An indicator of active infection is needed to facilitate the diagnosis of cytomgalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus was detected in the leukocytes of both the peripheral blood and BALF during the early phase of the disease. |
|||
Cytomegalovirus Antibody / CMV / PP65 |
|||
| V2333-100UG | NSJ Bioreagents | 100 ug | 424.15 EUR |
|
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, cytomegalovirus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of cytomegalovirus disease. An indicator of active CMV infection is needed to facilitate the diagnosis of cytomegalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease. |
|||
Cytomegalovirus Antibody / CMV / PP65 |
|||
| V2333-20UG | NSJ Bioreagents | 20 ug | 186.15 EUR |
|
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, cytomegalovirus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of cytomegalovirus disease. An indicator of active CMV infection is needed to facilitate the diagnosis of cytomegalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease. |
|||
Cytomegalovirus Antibody / CMV / PP65 |
|||
| V2333SAF-100UG | NSJ Bioreagents | 100 ug | 424.15 EUR |
|
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, cytomegalovirus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of cytomegalovirus disease. An indicator of active CMV infection is needed to facilitate the diagnosis of cytomegalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease. |
|||
Cytomegalovirus (CMV) Chimeric 1 Protein |
|||
| abx061513-1mg | Abbexa | 1 mg | 1796.4 EUR |
Cytomegalovirus (CMV) Chimeric 1 Protein |
|||
| abx061513-100g | Abbexa | 100 µg | Ask for price |
Cytomegalovirus (CMV) Chimeric 1 Protein |
|||
| abx061513-10g | Abbexa | 10 µg | 2087.5 EUR |
Cytomegalovirus (CMV) Chimeric 1 Protein |
|||
| abx061513-50g | Abbexa | 50 µg | Ask for price |
Human Cytomegalovirus (CMV) IgG ELISA Kit |
|||
| IHUCMVIGGKT | Innovative research | each | 528 EUR |
|
Description: Human Cytomegalovirus (CMV) IgG ELISA Kit |
|||